Medicare Part D Protected Classes Retained For 2011, With Exceptions Process, In Final CMS Rule
This article was originally published in The Pink Sheet Daily
Medicare Part D formulary requirements for the six "protected" classes will be maintained through 2011 and until the agency establishes otherwise through rulemaking, under a final rule slated for April 15 publication.
You may also be interested in...
A proposed Medicare rule says under new criteria CMS has developed, antidepressants and immunosuppressants will no longer be protected classes in plan formularies, but antineoplastics, antiretrovirals and anticonvulsants will remain. Antipsychotics will also be protected through 2015 as CMS continues to evaluate the class.
CMS' latest take on policy for "protected classes" under Medicare Part D identifies three key issues that will shape how such classes are chosen in the future: defining terms used in the statutory language, a new approach to the agency's previously proposed multi-step process for evaluating classes, and options for public comment on the agency's choices
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.